Reduced renal function strongly affects survival and thrombosis in patients with myelofibrosis-Reference-Cited by-同舟云学术

Reduced renal function strongly affects survival and thrombosis in patients with myelofibrosis

Published:2020-08-29 Issue:12 Volume:99 Page:2779-2785
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Lucijanic Marko^ORCID,Galusic Davor,Krecak Ivan,Sedinic Martina,Holik Hrvoje,Perisa Vlatka,Moric Peric Martina,Zekanovic Ivan,Stoos-Veic Tajana,Kusec Rajko

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-020-04239-4.pdf

Reference27 articles.

1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391–2405. https://doi.org/10.1182/blood-2016-03-643544

2. Hasselbalch HC, Bjørn ME (2015) MPNs as inflammatory diseases: the evidence, consequences, and perspectives. Mediat Inflamm 2015:102476–102416. https://doi.org/10.1155/2015/102476

3. Hultcrantz M, Kristinsson SY, Andersson TM, Landgren O, Eloranta S, Derolf AR, Dickman PW, Bjorkholm M (2012) Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study. J Clin Oncol 30(24):2995–3001. https://doi.org/10.1200/JCO.2012.42.1925

4. Passamonti F, Cervantes F, Vannucchi AM, Morra E, Rumi E, Pereira A, Guglielmelli P, Pungolino E, Caramella M, Maffioli M, Pascutto C, Lazzarino M, Cazzola M, Tefferi A (2010) A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). Blood 115(9):1703–1708. https://doi.org/10.1182/blood-2009-09-245837

5. Passamonti F, Giorgino T, Mora B, Guglielmelli P, Rumi E, Maffioli M, Rambaldi A, Caramella M, Komrokji R, Gotlib J, Kiladjian JJ, Cervantes F, Devos T, Palandri F, De Stefano V, Ruggeri M, Silver RT, Benevolo G, Albano F, Caramazza D, Merli M, Pietra D, Casalone R, Rotunno G, Barbui T, Cazzola M, Vannucchi AM (2017) A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis. Leukemia 31(12):2726–2731. https://doi.org/10.1038/leu.2017.169

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analisis Perbedaan Struktur Organisasi antara Perusahaan CV dan PT dalam Konteks Pengelolaan Sumber Daya Manusia;Indonesian Journal of Law and Justice;2024-05-27

2. Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis;Life;2024-04-17

3. The role of leukocytes in myeloproliferative neoplasm thromboinflammation;Journal of Leukocyte Biology;2024-03-25

4. Presence and Onset of Chronic Kidney Disease as a Factor Involved in the Poor Prognosis of Patients with Essential Thrombocythemia;Advances in Hematology;2024-01

5. Ph-Negative Chronic Myeloproliferative Neoplasms;Comprehensive Hematology and Stem Cell Research;2024